中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
7期
23-24
,共2页
乙型肝炎病毒%苦参素%阿德福韦酯%补体C3%C-反应蛋白
乙型肝炎病毒%苦參素%阿德福韋酯%補體C3%C-反應蛋白
을형간염병독%고삼소%아덕복위지%보체C3%C-반응단백
Hepatitis B virus%Marine%Adefovir dipivoxil%Complement C3%C-reactive protein
目的:观察苦参素联合阿德福韦酯治疗对慢性乙肝(CHB)患者补体C3、CRP水平及乙型肝炎病毒(HBV)复制的影响。方法:164例CHB患者按随机数字表法分为观察组84例和对照组80例,两组均给予阿德福韦酯治疗48周,观察组在疗程的前24周联用苦参素。在治疗前、24周和48周分别检测补体C3、CRP及HBV-DNA水平。结果:治疗后24周及48周察组HBV-DNA转阴率均高于对照组(P<0.05);治疗后两组补体C3、CRP水平与治疗前比较均有统计学差异,且观察组补体C3水平高于对照组,CRP水平低于对照组,差异有统计学意义(P<0.05)。结论:苦参素联合阿德福韦酯治疗CHB可显著提高疗效,改善肝脏炎症活动和器官免疫功能。
目的:觀察苦參素聯閤阿德福韋酯治療對慢性乙肝(CHB)患者補體C3、CRP水平及乙型肝炎病毒(HBV)複製的影響。方法:164例CHB患者按隨機數字錶法分為觀察組84例和對照組80例,兩組均給予阿德福韋酯治療48週,觀察組在療程的前24週聯用苦參素。在治療前、24週和48週分彆檢測補體C3、CRP及HBV-DNA水平。結果:治療後24週及48週察組HBV-DNA轉陰率均高于對照組(P<0.05);治療後兩組補體C3、CRP水平與治療前比較均有統計學差異,且觀察組補體C3水平高于對照組,CRP水平低于對照組,差異有統計學意義(P<0.05)。結論:苦參素聯閤阿德福韋酯治療CHB可顯著提高療效,改善肝髒炎癥活動和器官免疫功能。
목적:관찰고삼소연합아덕복위지치료대만성을간(CHB)환자보체C3、CRP수평급을형간염병독(HBV)복제적영향。방법:164례CHB환자안수궤수자표법분위관찰조84례화대조조80례,량조균급여아덕복위지치료48주,관찰조재료정적전24주련용고삼소。재치료전、24주화48주분별검측보체C3、CRP급HBV-DNA수평。결과:치료후24주급48주찰조HBV-DNA전음솔균고우대조조(P<0.05);치료후량조보체C3、CRP수평여치료전비교균유통계학차이,차관찰조보체C3수평고우대조조,CRP수평저우대조조,차이유통계학의의(P<0.05)。결론:고삼소연합아덕복위지치료CHB가현저제고료효,개선간장염증활동화기관면역공능。
Objective:To investigate the effects of marine in combination with adefovir dipivoxil on C3,C-reation protein and replication of HBV in patients with chronic hepatitis B(CHB). Method:164 CHB patients were randomly divided into observation group(84 cases)and the control group(80 cases). All were given adefovir dipivoxil therapy for 48 weeks,and patients in observation group were combined with matrine at the first 24 weeks. The level of C3,CRP and HBV-DNA were detected before and 24 weeks and 48 weeks after treatment. Result:24 weeks and 48 weeks after treatment,the negative rate of HBV-DNA of observation group was higher than that of control group(P<0.05). The C3,CRP levels of the two groups after treatment were significant differences compared with those before treatment,and the C3 level of observation group was higher than that of control group,and the level of CRP was lower than that of control group,the difference was statistically significant(P<0.05). Conclusion:Marine combined with adefovir dipivoxil in the treatment of CHB can significantly improve the curative effect,and the hepatic inflammatory activity and organism immune function.